Cargando…
Sarcopenia in daily practice: assessment and management
BACKGROUND: Sarcopenia is increasingly recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes including falls, fractures, frailty and mortality. Several tools have been recommended to assess muscle mass, muscle strength and physical performance in clinica...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052976/ https://www.ncbi.nlm.nih.gov/pubmed/27716195 http://dx.doi.org/10.1186/s12877-016-0349-4 |
_version_ | 1782458324617265152 |
---|---|
author | Beaudart, Charlotte McCloskey, Eugène Bruyère, Olivier Cesari, Matteo Rolland, Yves Rizzoli, René Araujo de Carvalho, Islène Amuthavalli Thiyagarajan, Jotheeswaran Bautmans, Ivan Bertière, Marie-Claude Brandi, Maria Luisa Al-Daghri, Nasser M. Burlet, Nansa Cavalier, Etienne Cerreta, Francesca Cherubini, Antonio Fielding, Roger Gielen, Evelien Landi, Francesco Petermans, Jean Reginster, Jean-Yves Visser, Marjolein Kanis, John Cooper, Cyrus |
author_facet | Beaudart, Charlotte McCloskey, Eugène Bruyère, Olivier Cesari, Matteo Rolland, Yves Rizzoli, René Araujo de Carvalho, Islène Amuthavalli Thiyagarajan, Jotheeswaran Bautmans, Ivan Bertière, Marie-Claude Brandi, Maria Luisa Al-Daghri, Nasser M. Burlet, Nansa Cavalier, Etienne Cerreta, Francesca Cherubini, Antonio Fielding, Roger Gielen, Evelien Landi, Francesco Petermans, Jean Reginster, Jean-Yves Visser, Marjolein Kanis, John Cooper, Cyrus |
author_sort | Beaudart, Charlotte |
collection | PubMed |
description | BACKGROUND: Sarcopenia is increasingly recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes including falls, fractures, frailty and mortality. Several tools have been recommended to assess muscle mass, muscle strength and physical performance in clinical trials. Whilst these tools have proven to be accurate and reliable in investigational settings, many are not easily applied to daily practice. METHODS: This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were afterwards organized for the whole group to make amendments and discuss further recommendations. RESULTS: This paper proposes some user-friendly and inexpensive methods that can be used to assess sarcopenia in real-life settings. Healthcare providers, particularly in primary care, should consider an assessment of sarcopenia in individuals at increased risk; suggested tools for assessing risk include the Red Flag Method, the SARC-F questionnaire, the SMI method or different prediction equations. Management of sarcopenia should primarily be patient centered and involve the combination of both resistance and endurance based activity programmes with or without dietary interventions. Development of a number of pharmacological interventions is also in progress. CONCLUSIONS: Assessment of sarcopenia in individuals with risk factors, symptoms and/or conditions exposing them to the risk of disability will become particularly important in the near future. |
format | Online Article Text |
id | pubmed-5052976 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50529762016-10-06 Sarcopenia in daily practice: assessment and management Beaudart, Charlotte McCloskey, Eugène Bruyère, Olivier Cesari, Matteo Rolland, Yves Rizzoli, René Araujo de Carvalho, Islène Amuthavalli Thiyagarajan, Jotheeswaran Bautmans, Ivan Bertière, Marie-Claude Brandi, Maria Luisa Al-Daghri, Nasser M. Burlet, Nansa Cavalier, Etienne Cerreta, Francesca Cherubini, Antonio Fielding, Roger Gielen, Evelien Landi, Francesco Petermans, Jean Reginster, Jean-Yves Visser, Marjolein Kanis, John Cooper, Cyrus BMC Geriatr Debate BACKGROUND: Sarcopenia is increasingly recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes including falls, fractures, frailty and mortality. Several tools have been recommended to assess muscle mass, muscle strength and physical performance in clinical trials. Whilst these tools have proven to be accurate and reliable in investigational settings, many are not easily applied to daily practice. METHODS: This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were afterwards organized for the whole group to make amendments and discuss further recommendations. RESULTS: This paper proposes some user-friendly and inexpensive methods that can be used to assess sarcopenia in real-life settings. Healthcare providers, particularly in primary care, should consider an assessment of sarcopenia in individuals at increased risk; suggested tools for assessing risk include the Red Flag Method, the SARC-F questionnaire, the SMI method or different prediction equations. Management of sarcopenia should primarily be patient centered and involve the combination of both resistance and endurance based activity programmes with or without dietary interventions. Development of a number of pharmacological interventions is also in progress. CONCLUSIONS: Assessment of sarcopenia in individuals with risk factors, symptoms and/or conditions exposing them to the risk of disability will become particularly important in the near future. BioMed Central 2016-10-05 /pmc/articles/PMC5052976/ /pubmed/27716195 http://dx.doi.org/10.1186/s12877-016-0349-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Debate Beaudart, Charlotte McCloskey, Eugène Bruyère, Olivier Cesari, Matteo Rolland, Yves Rizzoli, René Araujo de Carvalho, Islène Amuthavalli Thiyagarajan, Jotheeswaran Bautmans, Ivan Bertière, Marie-Claude Brandi, Maria Luisa Al-Daghri, Nasser M. Burlet, Nansa Cavalier, Etienne Cerreta, Francesca Cherubini, Antonio Fielding, Roger Gielen, Evelien Landi, Francesco Petermans, Jean Reginster, Jean-Yves Visser, Marjolein Kanis, John Cooper, Cyrus Sarcopenia in daily practice: assessment and management |
title | Sarcopenia in daily practice: assessment and management |
title_full | Sarcopenia in daily practice: assessment and management |
title_fullStr | Sarcopenia in daily practice: assessment and management |
title_full_unstemmed | Sarcopenia in daily practice: assessment and management |
title_short | Sarcopenia in daily practice: assessment and management |
title_sort | sarcopenia in daily practice: assessment and management |
topic | Debate |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052976/ https://www.ncbi.nlm.nih.gov/pubmed/27716195 http://dx.doi.org/10.1186/s12877-016-0349-4 |
work_keys_str_mv | AT beaudartcharlotte sarcopeniaindailypracticeassessmentandmanagement AT mccloskeyeugene sarcopeniaindailypracticeassessmentandmanagement AT bruyereolivier sarcopeniaindailypracticeassessmentandmanagement AT cesarimatteo sarcopeniaindailypracticeassessmentandmanagement AT rollandyves sarcopeniaindailypracticeassessmentandmanagement AT rizzolirene sarcopeniaindailypracticeassessmentandmanagement AT araujodecarvalhoislene sarcopeniaindailypracticeassessmentandmanagement AT amuthavallithiyagarajanjotheeswaran sarcopeniaindailypracticeassessmentandmanagement AT bautmansivan sarcopeniaindailypracticeassessmentandmanagement AT bertieremarieclaude sarcopeniaindailypracticeassessmentandmanagement AT brandimarialuisa sarcopeniaindailypracticeassessmentandmanagement AT aldaghrinasserm sarcopeniaindailypracticeassessmentandmanagement AT burletnansa sarcopeniaindailypracticeassessmentandmanagement AT cavalieretienne sarcopeniaindailypracticeassessmentandmanagement AT cerretafrancesca sarcopeniaindailypracticeassessmentandmanagement AT cherubiniantonio sarcopeniaindailypracticeassessmentandmanagement AT fieldingroger sarcopeniaindailypracticeassessmentandmanagement AT gielenevelien sarcopeniaindailypracticeassessmentandmanagement AT landifrancesco sarcopeniaindailypracticeassessmentandmanagement AT petermansjean sarcopeniaindailypracticeassessmentandmanagement AT reginsterjeanyves sarcopeniaindailypracticeassessmentandmanagement AT vissermarjolein sarcopeniaindailypracticeassessmentandmanagement AT kanisjohn sarcopeniaindailypracticeassessmentandmanagement AT coopercyrus sarcopeniaindailypracticeassessmentandmanagement |